A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Chemotherapy drugs use different ways to stop cancer cells from dividing so they stop growing
or die. Zosuquidar may help Gemtuzumab Ozogamicin (GO) kill more cancer cells by making
cancer cells more sensitive to the drug. It is not known whether Gemtuzumab Ozogamicin (GO)
is more effective with or without zosuquidar in treating acute myeloid leukemia.